Asif Alavi

408 total citations
14 papers, 74 citations indexed

About

Asif Alavi is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Asif Alavi has authored 14 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Asif Alavi's work include Hematopoietic Stem Cell Transplantation (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Asif Alavi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Asif Alavi collaborates with scholars based in United States. Asif Alavi's co-authors include Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol, Lois Ayash, Seongho Kim, Dipenkumar Modi, Vijendra K. Singh, Lakshmanan Krishnamurti, Mark C. Walters and David J. Reiner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Asif Alavi

13 papers receiving 74 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asif Alavi United States	6	41	26	17	17	13	14	74
Kannadit Prayongratana Thailand	5	42 1.0×	13 0.5×	15 0.9×	32 1.9×	11 0.8×	20	75
Nolwenn Lucas France	5	55 1.3×	33 1.3×	34 2.0×	15 0.9×	11 0.8×	9	99
Alison J. Potter Australia	6	31 0.8×	34 1.3×	7 0.4×	33 1.9×	15 1.2×	17	97
Nathalie Jacque France	5	41 1.0×	19 0.7×	14 0.8×	9 0.5×	7 0.5×	6	69
Nobuo Sezaki Japan	7	48 1.2×	23 0.9×	18 1.1×	11 0.6×	9 0.7×	13	104
Domenico Magro Italy	4	82 2.0×	37 1.4×	20 1.2×	18 1.1×	10 0.8×	5	109
Virginie Chesnais France	5	55 1.3×	42 1.6×	30 1.8×	13 0.8×	7 0.5×	13	104
Marie‐Agnès Collonge‐Rame France	5	36 0.9×	23 0.9×	19 1.1×	13 0.8×	9 0.7×	11	69
Shunsuke Yui Japan	6	68 1.7×	34 1.3×	33 1.9×	16 0.9×	7 0.5×	18	111
Marwan Shaheen Saudi Arabia	7	48 1.2×	16 0.6×	11 0.6×	14 0.8×	3 0.2×	17	74

Countries citing papers authored by Asif Alavi

Since Specialization

Citations

This map shows the geographic impact of Asif Alavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asif Alavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asif Alavi more than expected).

Fields of papers citing papers by Asif Alavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asif Alavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asif Alavi. The network helps show where Asif Alavi may publish in the future.

Co-authorship network of co-authors of Asif Alavi

This figure shows the co-authorship network connecting the top 25 collaborators of Asif Alavi. A scholar is included among the top collaborators of Asif Alavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asif Alavi. Asif Alavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Alavi, Asif, Lakshmanan Krishnamurti, Mehrdad Abedi, et al.. (2021). Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD). Blood. 138(Supplement 1). 2930–2930. 22 indexed citations

Shah, Harsh, Hyejeong Jang, Asif Alavi, et al.. (2021). Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents. Leukemia & lymphoma. 63(4). 813–820. 4 indexed citations

Modi, Dipenkumar, Seongho Kim, Lois Ayash, et al.. (2020). Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma. Leukemia & lymphoma. 61(8). 1877–1884. 2 indexed citations

Albanyan, Omar, Seongho Kim, Abhinav Deol, et al.. (2020). Grade III-IV cytokine release syndrome is associated with inferior survival in patients undergoing haploidentical donor stem cell transplants.. Journal of Clinical Oncology. 38(15_suppl). 7546–7546. 1 indexed citations

Modi, Dipenkumar, Omar Albanyan, Seongho Kim, et al.. (2020). Toxicities after high dose post-transplant cyclophosphamide in haploidentical donor transplants: Risk factors and impact on survival.. Journal of Clinical Oncology. 38(15_suppl). 7545–7545. 1 indexed citations

Singh, Vijendra K., Hyejeong Jang, Seongho Kim, et al.. (2020). G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD. Leukemia & lymphoma. 62(2). 446–453. 7 indexed citations

Modi, Dipenkumar, Seongho Kim, Lois Ayash, et al.. (2019). R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation. 26(4). 683–690. 5 indexed citations

Modi, Dipenkumar, Seongho Kim, Lois Ayash, et al.. (2019). Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma. Leukemia Research. 83. 106171–106171. 1 indexed citations

Shah, Harsh, Seongho Kim, Asif Alavi, et al.. (2019). Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts. American Journal of Hematology. 95(2). 198–204. 9 indexed citations

10.

Modi, Dipenkumar, Seongho Kim, Lois Ayash, et al.. (2019). Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival. Blood. 134(Supplement_1). 3311–3311.

11.

Modi, Dipenkumar, Jing Christine Ye, Vijendra K. Singh, et al.. (2019). Liver Graft‐Versus‐Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients. American Journal of Hematology. 94(10). 1072–1080. 10 indexed citations

12.

Modi, Dipenkumar, Seongho Kim, Vijendra K. Singh, et al.. (2019). Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome. Leukemia & lymphoma. 60(11). 2762–2770. 7 indexed citations

13.

Modi, Dipenkumar, Seongho Kim, Abhinav Deol, et al.. (2018). Long Term Outcomes of Allogeneic Transplant in Diffuse Large B-Cell Lymphoma. Blood. 132(Supplement 1). 5769–5769. 3 indexed citations

14.

Kim, Seongho, Joseph P. Uberti, Voravit Ratanatharathorn, et al.. (2017). A Retrospective Comparison of Outcomes in AML/MDS Patients Undergoing Allogeneic Stem Cell Transplant with Reduced Intensity and Myeloablative Conditioning Regimens. Biology of Blood and Marrow Transplantation. 23(3). S258–S258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact